Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-11-19
DOI
10.3389/fonc.2019.01266
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles
- (2019) Eline Oeyen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine
- (2019) Giovanna Rossi et al. CANCER RESEARCH
- Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal Cystoscopy
- (2019) Badrinath Konety et al. EUROPEAN UROLOGY
- Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
- (2019) Yohann Loriot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Profiling of Liquid Biopsy Samples for Precision Medicine
- (2018) Camila D.M. Campos et al. CANCER JOURNAL
- Conservative Management Following Clinical Complete Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study
- (2018) Patrick Mazza et al. JOURNAL OF UROLOGY
- Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA
- (2018) Davina Gale et al. PLoS One
- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- Identification of oncogenic long noncoding RNA SNHG12 and DUXAP8 in human bladder cancer through a comprehensive profiling analysis
- (2018) Bin Jiang et al. BIOMEDICINE & PHARMACOTHERAPY
- Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib
- (2018) Geoffrey R. Oxnard et al. JAMA Oncology
- Detection and surveillance of bladder cancer using urine tumor DNA
- (2018) Jonathan C. Dudley et al. Cancer Discovery
- Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer
- (2018) Fatemeh Yazarlou et al. Cancer Management and Research
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
- (2017) Marko Babjuk et al. EUROPEAN UROLOGY
- Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets
- (2017) Cecilia Pop-Bica et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy
- (2017) Kim E.M. van Kessel et al. JOURNAL OF UROLOGY
- DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification
- (2017) Lixin Chen et al. SCIENCE
- Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma
- (2017) Yair Lotan et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer
- (2017) Anna Katharina Seitz et al. Scientific Reports
- Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
- (2017) K. M. Patel et al. Scientific Reports
- Genomic characterization of response to chemoradiation in urothelial bladder cancer
- (2016) Neil B. Desai et al. CANCER
- Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA
- (2016) Fiona S Togneri et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer
- (2016) Karin Birkenkamp-Demtröder et al. EUROPEAN UROLOGY
- Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations
- (2016) Noura J. Choudhury et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated digital error suppression for improved detection of circulating tumor DNA
- (2016) Aaron M Newman et al. NATURE BIOTECHNOLOGY
- Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
- (2015) J. Tie et al. ANNALS OF ONCOLOGY
- A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion® FISH, NMP22® and cytology based on imputation of multiple datasets
- (2015) Vivienne Breen et al. BMC Medical Research Methodology
- The translational potential of circulating tumour DNA in oncology
- (2015) K.M. Patel et al. CLINICAL BIOCHEMISTRY
- Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
- (2015) Elizabeth R. Plimack et al. EUROPEAN UROLOGY
- The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study
- (2015) Camille Couffignal et al. UROLOGY
- Carcinoma In Situ Is Significantly Underdetected by Prenephroureterectomy Ureteroscopy in the Management of Upper Tract Urothelial Cancers
- (2015) Angela Gillan et al. Biomed Research International
- Filtration Device for On-Site Collection, Storage and Shipment of Cells from Urine and Its Application to DNA-Based Detection of Bladder Cancer
- (2015) Elin Andersson et al. PLoS One
- Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer
- (2015) Erina Takai et al. Scientific Reports
- Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
- (2014) F. Rothé et al. ANNALS OF ONCOLOGY
- MicroRNAome genome: A treasure for cancer diagnosis and therapy
- (2014) Ioana Berindan-Neagoe et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Re: Yves Allorya, Willemien Beukers, Ana Sagrera, et al. Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome. Eur Urol 2014;65:360–6
- (2014) Jayant K. Rane et al. EUROPEAN UROLOGY
- Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity
- (2014) Elizabeth R. Plimack et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates
- (2014) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- The Natural History of Clinically Complete Responders to Neoadjuvant Chemotherapy for Urothelial Carcinoma of the Bladder
- (2014) Alexa Meyer et al. JOURNAL OF UROLOGY
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
- (2014) Aaron M Newman et al. NATURE MEDICINE
- Mutational Context and Diverse Clonal Development in Early and Late Bladder Cancer
- (2014) Iver Nordentoft et al. Cell Reports
- Evaluation of urovysion and cytology for bladder cancer detection
- (2013) Haythem Dimashkieh et al. CANCER CYTOPATHOLOGY
- TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine
- (2013) I. Kinde et al. CANCER RESEARCH
- Comprehensive Mutation Analysis of the TERT Promoter in Bladder Cancer and Detection of Mutations in Voided Urine
- (2013) Carolyn D. Hurst et al. EUROPEAN UROLOGY
- Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer
- (2013) Elena S. Martens-Uzunova et al. EUROPEAN UROLOGY
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- Epidemiology and Risk Factors of Urothelial Bladder Cancer
- (2012) Maximilian Burger et al. EUROPEAN UROLOGY
- A Multigene Urine Test for the Detection and Stratification of Bladder Cancer in Patients Presenting with Hematuria
- (2012) Paul O'Sullivan et al. JOURNAL OF UROLOGY
- FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing
- (2012) Isaac Kinde et al. PLoS One
- Detection of ultra-rare mutations by next-generation sequencing
- (2012) M. W. Schmitt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
- (2012) T. Forshew et al. Science Translational Medicine
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
- (2011) Benjamin J. Hindson et al. ANALYTICAL CHEMISTRY
- Field guide to next-generation DNA sequencers
- (2011) TRAVIS C. GLENN Molecular Ecology Resources
- Detection and quantification of rare mutations with massively parallel sequencing
- (2011) I. Kinde et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibroblast Growth Factor Receptor 3 Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle-Invasive Bladder Cancer
- (2010) T. C. M. Zuiverloon et al. CLINICAL CANCER RESEARCH
- FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
- (2010) Lucie C. Kompier et al. PLoS One
- Small Endoscopic Biopsies of the Ureter and Renal Pelvis
- (2009) Fabio Tavora et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- A multicolour fluorescencein situhybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy
- (2009) Jared Whitson et al. BJU INTERNATIONAL
- The prognostic value of cytology and fluorescencein situhybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy
- (2009) Spasenija Savic et al. INTERNATIONAL JOURNAL OF CANCER
- Bladder Cancer Detection Using FISH (UroVysion Assay)
- (2008) Kevin C. Halling et al. ADVANCES IN ANATOMIC PATHOLOGY
- Novel therapeutic targets in bladder cancer: mutation and expression of FGF receptors
- (2008) Margaret A Knowles Future Oncology
- UroVysion FISH test for detecting urothelial cancers: Meta-analysis of diagnostic accuracy and comparison with urinary cytology testing
- (2008) Tine Hajdinjak UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More